Breast cancer: targeting the genome for better surveillance and
5 (202) · $ 8.50 · In stock
Team science advances breast cancer research at MUSC, MUSC
CRISPR/Cas9 system in breast cancer therapy: advancement, limitations and future scope, Cancer Cell International
miR-4759 suppresses breast cancer through immune checkpoint blockade - Computational and Structural Biotechnology Journal
Frontiers The Metabolic Mechanisms of Breast Cancer Metastasis
Genomics applied to the treatment of breast cancer
Frontiers Recent Progress on Immunotherapy for Breast Cancer: Tumor Microenvironment, Nanotechnology and More
Genomics to select treatment for patients with metastatic breast cancer
PDF] Targeting Cancer at the Nuclear Pore.
Recent advances in targeted strategies for triple-negative breast cancer, Journal of Hematology & Oncology
Unusual drug target and drug generate exciting preclinical results in mouse models of metastatic breast cancer
Single-cell RNA-seq dissects the intratumoral heterogeneity of triple-negative breast cancer based on gene regulatory networks - ScienceDirect
Chromosomal instability as central hallmark of Breast Cancer
